As one of the most common diseases in urology, a large number of preclinical studies have been accumulated to explore the etiological mechanism and potential intervention of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).In this study, we systematically evaluated the current status of preclinical research on CP/CPPS through bibliometrics analysis using VOSviewer and Citespace. Characteristics of publication such as year, country/region, institution, author, journal, citation, and keywords were analyzed. Based on the bibliometrics analysis results of keywords, we summarized the possible mechanisms and promising treatments for CP/CPPS narratively.According to the results of this study, the most common mechanisms involved in CP/CPPS were as follows: disturbed immune and inflammation mediators, immune cell dysfunction, oxidative stress, dysregulated signaling pathways, apoptosis, gut microbiota, and testosterone metabolism. Chinese Traditional Medicine and extracorporeal shock wave therapy have important potential in the treatment of CP/CPPS.Further translational studies targeting the above mechanisms and validating the objective efficacy of potential treatments indicated by preclinical studies in clinical patients are needed in the future.
{"title":"Molecular mechanism and promising treatments of chronic prostatitis/chronic pelvic pain syndrome: An exploratory bibliometric analysis and literature review of preclinical studies","authors":"Yongfeng Lao, Xin Guan, Jian Wang, Yanan Bai, Zewen Li, Zhiping Wang, Zhilong Dong","doi":"10.1002/uro2.34","DOIUrl":"https://doi.org/10.1002/uro2.34","url":null,"abstract":"As one of the most common diseases in urology, a large number of preclinical studies have been accumulated to explore the etiological mechanism and potential intervention of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).In this study, we systematically evaluated the current status of preclinical research on CP/CPPS through bibliometrics analysis using VOSviewer and Citespace. Characteristics of publication such as year, country/region, institution, author, journal, citation, and keywords were analyzed. Based on the bibliometrics analysis results of keywords, we summarized the possible mechanisms and promising treatments for CP/CPPS narratively.According to the results of this study, the most common mechanisms involved in CP/CPPS were as follows: disturbed immune and inflammation mediators, immune cell dysfunction, oxidative stress, dysregulated signaling pathways, apoptosis, gut microbiota, and testosterone metabolism. Chinese Traditional Medicine and extracorporeal shock wave therapy have important potential in the treatment of CP/CPPS.Further translational studies targeting the above mechanisms and validating the objective efficacy of potential treatments indicated by preclinical studies in clinical patients are needed in the future.","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"484 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139860282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liyue Mu, Xiang Zhu, Bing Yang, Lin Yang, Xiaofeng Xu, Yongwei Zhao, Dalin He
This paper explores the advancement and application of high‐power blue diode lasers in treating benign prostatic hyperplasia (BPH). Addressing the challenges posed by existing techniques, the study focuses on optimizing tissue removal methods. Energy platform for BPH should balance a range of factors, such as operative time, patient conditions, urinary functions, complications, durability, accessibility, and cost, all while prioritizing patient care. Blueray Medical's innovation of high‐power blue diode laser systems for BPH surgery is explored, with emphasis on achieving a balance among these considerations. By illustrating the biomedical effects of lasers and their interaction with soft tissues, particularly emphasizing the role of photon absorption by biomolecules and proteins in tissue behavior, this study outlines the advantages of the high‐power blue diode laser system. The initial laboratory experiments and clinical results consistently align with our theoretical predictions, especially in terms of tissue vaporization efficiency, tissue coagulation, and bleeding control. In conclusion, blue diode lasers hold potential to enhance surgical outcomes for BPH. Their unique properties offer benefits like improved tissue removal rate and reduced thermal damages. Integrating blue laser technology into BPH protocols could lead to shorter hospital stays, cost savings, and expanded patient eligibility, although rigorous clinical studies are needed to fully understand their benefits and limitations.
{"title":"Development of a high‐power blue diode laser for precision vaporization of prostate tissue for the surgical management of benign prostatic hyperplasia","authors":"Liyue Mu, Xiang Zhu, Bing Yang, Lin Yang, Xiaofeng Xu, Yongwei Zhao, Dalin He","doi":"10.1002/uro2.30","DOIUrl":"https://doi.org/10.1002/uro2.30","url":null,"abstract":"This paper explores the advancement and application of high‐power blue diode lasers in treating benign prostatic hyperplasia (BPH). Addressing the challenges posed by existing techniques, the study focuses on optimizing tissue removal methods. Energy platform for BPH should balance a range of factors, such as operative time, patient conditions, urinary functions, complications, durability, accessibility, and cost, all while prioritizing patient care. Blueray Medical's innovation of high‐power blue diode laser systems for BPH surgery is explored, with emphasis on achieving a balance among these considerations. By illustrating the biomedical effects of lasers and their interaction with soft tissues, particularly emphasizing the role of photon absorption by biomolecules and proteins in tissue behavior, this study outlines the advantages of the high‐power blue diode laser system. The initial laboratory experiments and clinical results consistently align with our theoretical predictions, especially in terms of tissue vaporization efficiency, tissue coagulation, and bleeding control. In conclusion, blue diode lasers hold potential to enhance surgical outcomes for BPH. Their unique properties offer benefits like improved tissue removal rate and reduced thermal damages. Integrating blue laser technology into BPH protocols could lead to shorter hospital stays, cost savings, and expanded patient eligibility, although rigorous clinical studies are needed to fully understand their benefits and limitations.","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"1 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139863620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liyue Mu, Xiang Zhu, Bing Yang, Lin Yang, Xiaofeng Xu, Yongwei Zhao, Dalin He
This paper explores the advancement and application of high‐power blue diode lasers in treating benign prostatic hyperplasia (BPH). Addressing the challenges posed by existing techniques, the study focuses on optimizing tissue removal methods. Energy platform for BPH should balance a range of factors, such as operative time, patient conditions, urinary functions, complications, durability, accessibility, and cost, all while prioritizing patient care. Blueray Medical's innovation of high‐power blue diode laser systems for BPH surgery is explored, with emphasis on achieving a balance among these considerations. By illustrating the biomedical effects of lasers and their interaction with soft tissues, particularly emphasizing the role of photon absorption by biomolecules and proteins in tissue behavior, this study outlines the advantages of the high‐power blue diode laser system. The initial laboratory experiments and clinical results consistently align with our theoretical predictions, especially in terms of tissue vaporization efficiency, tissue coagulation, and bleeding control. In conclusion, blue diode lasers hold potential to enhance surgical outcomes for BPH. Their unique properties offer benefits like improved tissue removal rate and reduced thermal damages. Integrating blue laser technology into BPH protocols could lead to shorter hospital stays, cost savings, and expanded patient eligibility, although rigorous clinical studies are needed to fully understand their benefits and limitations.
{"title":"Development of a high‐power blue diode laser for precision vaporization of prostate tissue for the surgical management of benign prostatic hyperplasia","authors":"Liyue Mu, Xiang Zhu, Bing Yang, Lin Yang, Xiaofeng Xu, Yongwei Zhao, Dalin He","doi":"10.1002/uro2.30","DOIUrl":"https://doi.org/10.1002/uro2.30","url":null,"abstract":"This paper explores the advancement and application of high‐power blue diode lasers in treating benign prostatic hyperplasia (BPH). Addressing the challenges posed by existing techniques, the study focuses on optimizing tissue removal methods. Energy platform for BPH should balance a range of factors, such as operative time, patient conditions, urinary functions, complications, durability, accessibility, and cost, all while prioritizing patient care. Blueray Medical's innovation of high‐power blue diode laser systems for BPH surgery is explored, with emphasis on achieving a balance among these considerations. By illustrating the biomedical effects of lasers and their interaction with soft tissues, particularly emphasizing the role of photon absorption by biomolecules and proteins in tissue behavior, this study outlines the advantages of the high‐power blue diode laser system. The initial laboratory experiments and clinical results consistently align with our theoretical predictions, especially in terms of tissue vaporization efficiency, tissue coagulation, and bleeding control. In conclusion, blue diode lasers hold potential to enhance surgical outcomes for BPH. Their unique properties offer benefits like improved tissue removal rate and reduced thermal damages. Integrating blue laser technology into BPH protocols could lead to shorter hospital stays, cost savings, and expanded patient eligibility, although rigorous clinical studies are needed to fully understand their benefits and limitations.","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139803877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Prostate cancer (PCa) is one of the most prevalent malignant tumors in men, accompanied by high incidence and mortality rates. Novel hormonal therapy (NHT) has emerged as the primary treatment for advanced PCa, providing noticeable clinical benefits. However, the diverse range of adverse events (AEs) associated with NHT may influence both treatment efficacy and patients' quality of life. In light of the latest international clinical research evidence and recommendations from domestic and foreign guidelines, this consensus aims to provide a comprehensive overview of the common AEs experienced during NHT for advanced PCa patients. Additionally, it seeks to develop a hierarchical approach to more efficiently manage AEs, presenting valuable insights for clinical medication and adverse reaction management.
{"title":"Consensus on safety management of novel hormonal therapy for advanced prostate cancer","authors":"Sujun Han, Shudong Cheng, Degang Ding, Jianming Guo, Zhisong He, Baiye Jin, Zhigang Ji, Tianxin Lin, Yuanjie Niu, Weijun Qin, Benkang Shi, Jinkai Shao, Xi'nan Sheng, Qiang Wei, Xin Wang, Xinghuan Wang, Shujie Xia, Wanhai Xu, Qing Zou, Xiongbing Zu, Renu Eapen, Chi‐Fai Ng, Hirotsugu Uemura, Hiroji Uemura, Cheol Kwak, Jae Young Joung, Marniza Saad, Edmund Chiong, Nianzeng Xing","doi":"10.1002/uro2.22","DOIUrl":"https://doi.org/10.1002/uro2.22","url":null,"abstract":"Prostate cancer (PCa) is one of the most prevalent malignant tumors in men, accompanied by high incidence and mortality rates. Novel hormonal therapy (NHT) has emerged as the primary treatment for advanced PCa, providing noticeable clinical benefits. However, the diverse range of adverse events (AEs) associated with NHT may influence both treatment efficacy and patients' quality of life. In light of the latest international clinical research evidence and recommendations from domestic and foreign guidelines, this consensus aims to provide a comprehensive overview of the common AEs experienced during NHT for advanced PCa patients. Additionally, it seeks to develop a hierarchical approach to more efficiently manage AEs, presenting valuable insights for clinical medication and adverse reaction management.","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"51 25","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138956982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kyle A. Blum, William Jones, Lauren Conroy, Justin Mehr, Travis Green, Run Wang
Abstract Background Patients with inflatable penile prostheses (IPP) may experience erosions after years of use or after indwelling Foley catheter placement. IPP erosions should be managed as an infection with the entire IPP removed. Replacing IPPs in erosion patients can be challenging due to extensive scarring development. Using proper graft materials may be necessary to close and reinforce the corporal defect after difficult corporal dilation or significant scar removal for the long‐term success of IPP reimplantation. Case Presentation Herein we report a patient with a history of IPP placement in 2007 for erectile dysfunction and Peyronie's disease, presenting in 2018 with dysuria and a feeling of IPP displacement following Foley catheter placement for coronary artery bypass graft surgery. The left cylinder of the IPP was observed by physical examination and a defect near the fossa navicularis was discovered during office cystoscopy. A complete explantation of IPP was then performed. Reimplantation of the IPP was performed in 2021 which required excision of corporal scar tissue and repair of a left distal corporal defect using a Tutoplast® pericardium allograft. The procedure was successful with proper IPP position and good function without any penile deformity. Conclusion The use of graft materials in the management of corporeal defects should be considered in the setting of complex IPP revision. The Tutoplast® pericardium allograft reinforcement can provide long‐term durability, flexibility, and a lower risk of infection.
{"title":"Complex reimplantation of an inflatable penile prosthesis with scar tissue excision and distal corporal defect repair with Tutoplast® pericardium allograft","authors":"Kyle A. Blum, William Jones, Lauren Conroy, Justin Mehr, Travis Green, Run Wang","doi":"10.1002/uro2.24","DOIUrl":"https://doi.org/10.1002/uro2.24","url":null,"abstract":"Abstract Background Patients with inflatable penile prostheses (IPP) may experience erosions after years of use or after indwelling Foley catheter placement. IPP erosions should be managed as an infection with the entire IPP removed. Replacing IPPs in erosion patients can be challenging due to extensive scarring development. Using proper graft materials may be necessary to close and reinforce the corporal defect after difficult corporal dilation or significant scar removal for the long‐term success of IPP reimplantation. Case Presentation Herein we report a patient with a history of IPP placement in 2007 for erectile dysfunction and Peyronie's disease, presenting in 2018 with dysuria and a feeling of IPP displacement following Foley catheter placement for coronary artery bypass graft surgery. The left cylinder of the IPP was observed by physical examination and a defect near the fossa navicularis was discovered during office cystoscopy. A complete explantation of IPP was then performed. Reimplantation of the IPP was performed in 2021 which required excision of corporal scar tissue and repair of a left distal corporal defect using a Tutoplast® pericardium allograft. The procedure was successful with proper IPP position and good function without any penile deformity. Conclusion The use of graft materials in the management of corporeal defects should be considered in the setting of complex IPP revision. The Tutoplast® pericardium allograft reinforcement can provide long‐term durability, flexibility, and a lower risk of infection.","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136134889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The World Chinese Urological Society (WCUS) stands as a dynamic and influential force in uniting professionals of Chinese descent from around the globe. Established with the vision of fostering collaboration, innovation, and knowledge exchange, WCUS serves as a beacon of excellence within the urological community. By providing a forum for urologists, andrologists, and urology/andrology scientists, WCUS is a crucible for exchanging cutting-edge research, groundbreaking techniques, and clinical insights. Through its annual meetings and conferences, WCUS nurtures a culture of shared expertise, where luminaries from China (including Taiwan, Hong Kong, and Macao), Singapore, Malaysia, Australia, and beyond, converge to shape the trajectory of urology. These gatherings facilitate the exploration of diverse facets of the field, from andrology to oncology, offering a tapestry of insights that enrich the practice and research of urology. WCUS not only honors past achievements but also champions the future. By spotlighting rising stars, offering mentorship, and recognizing exceptional contributions through awards, the society invests in the next generation of urological leaders. This commitment ensures that the legacy of WCUS continues to illuminate the path forward for urology. The society keeps pace with technological advancements, explores groundbreaking treatments, and engages with interdisciplinary collaborations that push the boundaries of urological understanding. With a forward-looking mindset, WCUS remains a vanguard of progress within the urology landscape. Beyond its academic pursuits, WCUS extends its impact through international partnerships, forging connections that span continents. By fostering relationships with urological associations and experts worldwide, the society contributes to a global network of professionals united by a shared passion for advancing urological knowledge and patient care. Founded by eight urologists on February 22, 1902, the American Urological Association (AUA), has been holding annual meetings at which world-class urologists and uroscientists give state-of-the-art lectures and present new discoveries in plenary sessions, poster sessions, symposiums, and postgraduate courses. There are more than 20 000 urologists of Chinese descent in the world, and many have actively participated in the activities of the AUA. These Chinese urologists had become integral to the AUA's activities, actively contributing to its programs and initiatives. In 2005, Dr. Joseph N. Corriere Jr., the President of the AUA at the time, and Dr. Carl A. Olsson, the Secretary, championed a groundbreaking idea in response to the request of Dr. Tom F. Lue. Recognizing the contributions and potential of Chinese urologists, they authorized establishing a Chinese urology program within the annual AUA meeting. This visionary concept resonated deeply with Chinese urologists globally, igniting a wave of enthusiastic support. Dr. Corriere Jr. then visited
世界华人泌尿外科学会(WCUS)是一个充满活力和影响力的力量，团结来自世界各地的华人专业人士。WCUS以促进合作、创新和知识交流为愿景而建立，是泌尿外科领域卓越的灯塔。通过为泌尿科医生、男科医生和泌尿科/男科科学家提供一个论坛，WCUS是一个交流前沿研究、突破性技术和临床见解的熔炉。通过其年度会议和会议，WCUS培养了一种共享专业知识的文化，来自中国(包括台湾、香港和澳门)、新加坡、马来西亚、澳大利亚等地的杰出人士汇聚一堂，共同塑造泌尿外科的发展轨迹。这些聚会促进了该领域的各个方面的探索，从男科到肿瘤学，提供了丰富泌尿科实践和研究的见解。WCUS不仅是对过去的荣誉，也是对未来的荣誉。通过关注冉冉升起的明星，提供指导，并通过奖励来表彰杰出的贡献，该协会投资于下一代泌尿学领导者。这一承诺确保WCUS的遗产继续照亮泌尿外科的前进道路。该协会与技术进步保持同步，探索突破性的治疗方法，并参与跨学科合作，推动泌尿学理解的界限。具有前瞻性的心态，WCUS仍然是泌尿外科领域进步的先锋。除了学术追求之外，WCUS还通过国际合作伙伴关系扩大其影响力，建立跨越各大洲的联系。通过促进与全球泌尿学协会和专家的关系，协会为促进泌尿学知识和患者护理的共同热情团结在一起，为全球专业人士网络做出了贡献。美国泌尿学协会(AUA)于1902年2月22日由8位泌尿科医生创立，每年都会举行年会，在全体会议、海报会议、专题讨论会和研究生课程中，世界一流的泌尿科医生和泌尿科学家会发表最先进的演讲，并展示新的发现。全世界有2万多名华裔泌尿科医生，许多人积极参与美国泌尿学会的活动。这些中国泌尿科医生已经成为美国泌尿协会活动不可或缺的一部分，积极为其项目和倡议做出贡献。2005年，当时的美国大学协会主席小约瑟夫·n·科里埃博士和秘书长卡尔·a·奥尔森博士响应汤姆·f·卢博士的请求，提出了一个开创性的想法。认识到中国泌尿科医师的贡献和潜力，他们授权在年度美国泌尿学会会议上建立一个中国泌尿科项目。这一富有远见的理念在全球的中国泌尿科医生中引起了深刻的共鸣，引发了一波热烈的支持。2005年底，在德克萨斯大学安德森癌症中心与Corriere Jr.在同一泌尿外科工作的王润医生的安排下，Corriere Jr.博士访问了中国，并会见了中国泌尿外科协会(CUA)的主要领导。Corriere博士对中国的历史性访问激发了美国泌尿学会和世界泌尿外科华人社区的极大兴趣，他们希望建立一个专门针对华裔泌尿科医生和泌尿外科科学家的美国泌尿学会亚社团项目。这个分会后来被汤姆·f·卢博士命名为“世界华人泌尿学会”。首届WCUS会议于2006年5月20日[1]在美国大学协会年会的框架内，在佐治亚州亚特兰大召开。这次重要的聚会标志着WCUS的诞生，并巩固了它与AUA的关系。在首次会议上，受人尊敬的郭应禄、张学衡、孙东天等院士担任了主持人。中国泌尿外科现状讲座由中国五个地区泌尿外科学会会长(中国泌尿外科学会会长纳彦群;余大勇台湾泌尿外科学会会长Christopher Cheng，新加坡泌尿外科协会主席;志伟文香港泌尿外科学会会长和澳门泌尿外科协会主席何子发先生)，进一步强调了合作和知识共享的精神。钟利兰在协调首期项目方面发挥了关键作用，促成了前所未有的支持和接触。这次会议开创了中国泌尿科医师和泌尿科学家超越地域界限的同志情谊、相互尊重和深度团结的新时代。在成功的成立会议后，Tom F. Lue和Run Wang决定将WCUS注册为美国德克萨斯州的非营利科学组织。WCUS名义下的申请被德克萨斯州拒绝，因为“世界”被其他组织采用。 这些活动的中心是在美国旧金山，300多名国际专家和与会者的虚拟参与为我们的WCUS2022会议的成功做出了明确的贡献。由于持续的全球旅行限制，第15届WCUS年会与中国泌尿外科医生协会年会于2023年7月16日在中国太原举行。这次会议证明了该学会对学术交流的持久承诺。作为会议的基石，WCUS终身成就奖和WCUS明日之星奖突出了对泌尿外科的杰出贡献。通过表彰成就和培养新兴人才，这些奖项强化了协会推动该领域进步的使命。超过42名杰出的泌尿科医生和泌尿科科学家被WCUS表彰为他们的终身贡献(表3)[1-14]。自2019年起[8]，WCUS明日之星奖被授予泌尿外科未来的领导者，这激发了我们社会中有才华的年轻泌尿科医生和泌尿科科学家的极大兴趣和参与(表4)[1-14]。WCUS在继续其增长，创新和全球合作的轨迹中大放异彩。在其丰富的历史和其前辈奠定的基础上，WCUS准备踏上一段旅程，将提升其作为首要泌尿学学会的地位，并为全球范围内泌尿学的进步做出重大贡献。在未来的几年里，WCUS设想其覆盖范围和影响力的动态扩展，巩固其作为前沿研究，创新患者护理和突破性发现的跨文化交流中心的作用。WCUS坚定不移地致力于促进全球泌尿科医生、男科医生和泌尿科/男科科学家之间的合作，将继续跨越地域界限，促进知识、专业知识和经验的共享。WCUS未来的标志之一在于其致力于培养下一代泌尿学领域的领导者和创新者。通过为后起之秀和年轻人才提供一个平台，该协会将培养和授权那些将塑造泌尿外科实践和研究未来的个人。通过指导、教育倡议和专业项目，WCUS将激励和支持新兴专业人士，确保为子孙后代留下卓越的遗产。随着技术和医学的进步，WCUS致力于走在创新的前沿。社会将继续接受新兴技术、新型治疗方式和变革性研究，营造一个让突破性思想蓬勃发展的环境。通过鼓励跨学科合作和推动传统泌尿学范式的界限，WCUS将在推动该领域的发展中发挥关键作用。此外，WCUS对国际伙伴关系和合作的承诺仍将是其未来努力的基石。协会将继续与世界各地的泌尿外科协会、机构和专家建立联盟，建立一个由泌尿外科共同热情联合起来的全球专业网络。通过联合倡议、交流计划和合作研究努力，WCUS将为国际泌尿外科的共同丰富做出贡献。在学术交流方面，WCUS将继续组织会议、专题讨论会和会议，为分享突破性研究、见解和临床经验提供平台。这些活动将促进学术讨论，探索新趋势，传播最佳实践，最终提高护理标准，改善患者预后。在拥抱数字时代的过程中，WCUS将利用技术扩大其影响和范围。通过利用在线平台、社交媒体和数字通信工具，该协会将促进其成员之间的持续参与和知识共享，确保思想交流超越物理界限，实现实时交流。最终，WCUS的未来将以对卓越、创新和合作的坚定承诺为特征。随着泌尿外科领域的不断发展，该协会将继续作为灵感的灯塔，进步的催化剂，以及全球泌尿外科社区的统一力量。通过其不懈的奉献，推进知识和患者护理的前沿，WCUS将塑造一个泌尿学达到成就和影响的新高度的未来。Tom F. luue, UroPrecision名誉总编辑，王润，林桂婷，UroPrecision副总编辑。 他们被排除在同行评审过程和所有与接受和发表这篇文章有关的编辑决定之外。同行评议由其他编辑独立处理，以尽量减少偏见。作者声明无利益冲突。作者对工作的各个方面负责，以确保与工作的任何部分的准确性或完整性相关的问题得到适当的调查和解决。
{"title":"History of World Chinese Urological Society (WCUS)","authors":"Guiting Lin, Run Wang, Richard Lo, Tom F. Lue","doi":"10.1002/uro2.25","DOIUrl":"https://doi.org/10.1002/uro2.25","url":null,"abstract":"The World Chinese Urological Society (WCUS) stands as a dynamic and influential force in uniting professionals of Chinese descent from around the globe. Established with the vision of fostering collaboration, innovation, and knowledge exchange, WCUS serves as a beacon of excellence within the urological community. By providing a forum for urologists, andrologists, and urology/andrology scientists, WCUS is a crucible for exchanging cutting-edge research, groundbreaking techniques, and clinical insights. Through its annual meetings and conferences, WCUS nurtures a culture of shared expertise, where luminaries from China (including Taiwan, Hong Kong, and Macao), Singapore, Malaysia, Australia, and beyond, converge to shape the trajectory of urology. These gatherings facilitate the exploration of diverse facets of the field, from andrology to oncology, offering a tapestry of insights that enrich the practice and research of urology. WCUS not only honors past achievements but also champions the future. By spotlighting rising stars, offering mentorship, and recognizing exceptional contributions through awards, the society invests in the next generation of urological leaders. This commitment ensures that the legacy of WCUS continues to illuminate the path forward for urology. The society keeps pace with technological advancements, explores groundbreaking treatments, and engages with interdisciplinary collaborations that push the boundaries of urological understanding. With a forward-looking mindset, WCUS remains a vanguard of progress within the urology landscape. Beyond its academic pursuits, WCUS extends its impact through international partnerships, forging connections that span continents. By fostering relationships with urological associations and experts worldwide, the society contributes to a global network of professionals united by a shared passion for advancing urological knowledge and patient care. Founded by eight urologists on February 22, 1902, the American Urological Association (AUA), has been holding annual meetings at which world-class urologists and uroscientists give state-of-the-art lectures and present new discoveries in plenary sessions, poster sessions, symposiums, and postgraduate courses. There are more than 20 000 urologists of Chinese descent in the world, and many have actively participated in the activities of the AUA. These Chinese urologists had become integral to the AUA's activities, actively contributing to its programs and initiatives. In 2005, Dr. Joseph N. Corriere Jr., the President of the AUA at the time, and Dr. Carl A. Olsson, the Secretary, championed a groundbreaking idea in response to the request of Dr. Tom F. Lue. Recognizing the contributions and potential of Chinese urologists, they authorized establishing a Chinese urology program within the annual AUA meeting. This visionary concept resonated deeply with Chinese urologists globally, igniting a wave of enthusiastic support. Dr. Corriere Jr. then visited ","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135617579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Background Although urethral trauma may lead to serious consequences if mismanaged, treatment concepts are inconsistent. We designed a survey to investigate the current diagnosis and management of emergency blunt urethral trauma to aid future dissemination of relevant concepts. Methods A 15‐item anonymous questionnaire was distributed via an online platform. It addressed items such as the cognition of how to diagnose of urethral trauma, optimal emergency management of a urethral trauma patient, and attitude towards early realignment for pelvic fracture urethral injuries. Results Of 538 respondents, 94.2% and 84.9% had received patients with straddle trauma urethral injuries or pelvic fracture urethral injuries, respectively, within the past year. In the emergency room, attempted urethral catheterization was the most selected examination method by respondents for diagnosis of both straddle injury (500/538) and pelvic fracture urethral injury (469/538). For patients with straddle injury, 41.3% of respondents performed endoscopic realignment and 31.6% preferred suprapubic cystostomy. For hemodynamically stable patients with PFUI, 42.2% of respondents preferred suprapubic cystostomy and 34.9% preferred endoscopic realignment. Most respondents felt favorably toward early realignment for pelvic fracture urethral injuries. After realignment, 61.3%, 24.5%, and 13.8% of respondents performed catheterization for 4, 8, and 12 weeks, respectively. Further, 54.6% of respondents believed catheter traction should be applied after realignment. Conclusion Although the number of yearly emergency urethral trauma cases was small, the opinions and practices of most urologists were consistent with guidelines. However, the significance of retrograde urethrography was not fully understood, and some respondents had incorrect views on catheter traction after realignment.
{"title":"A survey of emergency blunt urethral injury management in China: Reality versus guidelines","authors":"Yubo Gu, Changhao Hou, Jiahao Lin, Wei Yuan, Zeyu Wang, Xianjie Xiu, Qiang Fu, Lujie Song","doi":"10.1002/uro2.23","DOIUrl":"https://doi.org/10.1002/uro2.23","url":null,"abstract":"Abstract Background Although urethral trauma may lead to serious consequences if mismanaged, treatment concepts are inconsistent. We designed a survey to investigate the current diagnosis and management of emergency blunt urethral trauma to aid future dissemination of relevant concepts. Methods A 15‐item anonymous questionnaire was distributed via an online platform. It addressed items such as the cognition of how to diagnose of urethral trauma, optimal emergency management of a urethral trauma patient, and attitude towards early realignment for pelvic fracture urethral injuries. Results Of 538 respondents, 94.2% and 84.9% had received patients with straddle trauma urethral injuries or pelvic fracture urethral injuries, respectively, within the past year. In the emergency room, attempted urethral catheterization was the most selected examination method by respondents for diagnosis of both straddle injury (500/538) and pelvic fracture urethral injury (469/538). For patients with straddle injury, 41.3% of respondents performed endoscopic realignment and 31.6% preferred suprapubic cystostomy. For hemodynamically stable patients with PFUI, 42.2% of respondents preferred suprapubic cystostomy and 34.9% preferred endoscopic realignment. Most respondents felt favorably toward early realignment for pelvic fracture urethral injuries. After realignment, 61.3%, 24.5%, and 13.8% of respondents performed catheterization for 4, 8, and 12 weeks, respectively. Further, 54.6% of respondents believed catheter traction should be applied after realignment. Conclusion Although the number of yearly emergency urethral trauma cases was small, the opinions and practices of most urologists were consistent with guidelines. However, the significance of retrograde urethrography was not fully understood, and some respondents had incorrect views on catheter traction after realignment.","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135729728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract Infertility is a pervasive issue affecting a considerable proportion of couples in their reproductive years, with a projected 10%–15% prevalence. It is characterized by the incapability to achieve conception following a year of consistent, unprotected intercourse, and its far‐reaching consequences can take a profound emotional, psychological, and social toll on couples, inducing feelings of melancholy, exasperation, and anxiety. The appraisal of infertile couples' cases is a multifaceted and daunting process, necessitating a holistic understanding of the intricate underlying factors contributing to their infertility. Consequently, an individualized evaluation should be conducted, considering diverse parameters, such as the couple's medical history, age, infertility duration, and other relevant criteria. This paper will provide an in‐depth overview of the current approaches utilized in the evaluation of men with infertility, including the commonly employed diagnostic tools and procedures. Enhancing our comprehension of infertility assessment and management holds the promise of helping couples achieve their ultimate desire of conceiving and enriching their overall quality of life.
{"title":"Precise review of a male's infertility assessment from a men's health specialist prospective","authors":"Kareim Khalafalla, Laila Ammar, Run Wang","doi":"10.1002/uro2.21","DOIUrl":"https://doi.org/10.1002/uro2.21","url":null,"abstract":"Abstract Infertility is a pervasive issue affecting a considerable proportion of couples in their reproductive years, with a projected 10%–15% prevalence. It is characterized by the incapability to achieve conception following a year of consistent, unprotected intercourse, and its far‐reaching consequences can take a profound emotional, psychological, and social toll on couples, inducing feelings of melancholy, exasperation, and anxiety. The appraisal of infertile couples' cases is a multifaceted and daunting process, necessitating a holistic understanding of the intricate underlying factors contributing to their infertility. Consequently, an individualized evaluation should be conducted, considering diverse parameters, such as the couple's medical history, age, infertility duration, and other relevant criteria. This paper will provide an in‐depth overview of the current approaches utilized in the evaluation of men with infertility, including the commonly employed diagnostic tools and procedures. Enhancing our comprehension of infertility assessment and management holds the promise of helping couples achieve their ultimate desire of conceiving and enriching their overall quality of life.","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136374229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UroPrecisionVolume 1, Issue 1 p. vii-ix ISSUE INFORMATIONOpen Access Information for Authors First published: 24 July 2023 https://doi.org/10.1002/uro2.4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume1, Issue1March 2023Pages vii-ix RelatedInformation
UroPrecisionVolume 1, Issue 1 p. vii-ix Issue Information作者开放获取信息首次发布:2023年7月24日https://doi.org/10.1002/uro2.4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare给予accessShare全文accessShare全文accessShare请查看我们的使用条款和条件，并勾选下面的复选框共享文章的全文版本。我已经阅读并接受了Wiley在线图书馆使用共享链接的条款和条件，请使用下面的链接与您的朋友和同事分享本文的全文版本。学习更多的知识。复制URL共享链接共享一个emailfacebooktwitterlinkedinreddit微信本文无摘要第1卷，第1期，2023年3月
{"title":"Information for Authors","authors":"","doi":"10.1002/uro2.4","DOIUrl":"https://doi.org/10.1002/uro2.4","url":null,"abstract":"UroPrecisionVolume 1, Issue 1 p. vii-ix ISSUE INFORMATIONOpen Access Information for Authors First published: 24 July 2023 https://doi.org/10.1002/uro2.4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume1, Issue1March 2023Pages vii-ix RelatedInformation","PeriodicalId":478044,"journal":{"name":"UroPrecision","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135469419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：